Acquisition - February 10, 2025
Bain Capital acquires Mitsubishi Tanabe Pharma Corporation
Bain Capital has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation in a carve-out transaction from Mitsubishi Chemical Group Corporation.
Global report - January 24, 2025
AstraZeneca plans USD 570 million investment in Canada
The investment in Canada will create more than 700 high-skilled jobs, across all areas of the business.
Global report - January 21, 2025
Trump announces US withdrawal from WHO
President Donald Trump announced on Monday January 20 that the United States will leave the World Health Organization (WHO).
Acquisition - January 15, 2025
GSK to acquire IDRx for up to USD 1.15 billion
IDRx is a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment of GIST.
Agreement - January 14, 2025
Synthego signs strategic licensing agreement with AstraZeneca
This agreement grants Synthego a global license to manufacture and distribute AstraZeneca's novel CRISPR gene editing enzyme, eSpOT-ON, recently published as engineered ePsCas9, to the worldwide research community.
Global report - January 8, 2025
Stryker acquires Inari Medical
Stryker has announced a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical for USD 80 per share in cash, representing a total fully diluted equity value of approximately USD 4.9 billion.
